NeuroSolve aims to demonstrate and promote a methodological approach for conducting health research that will lead to improve adoption into policy, clinical practice and validate the approach by investigating, evaluating, and implementing an antiparasitic combination treatment for NCC and evaluating various serological test for diagnosis of Taeniasis and NCC.
The two health innovations could make a major positive contribution to neurocysticercosis management in Sub Saharan Africa and improve the health outcomes of NCC patients, providing a blueprint for meaningful implementation research, and demonstrate to policymakers how research can strengthen healthcare systems.
Home>The project